The aim of this study is to investigate wether intracoronary use of bolus Abciximab is
superior to intravenous bolus in patients undergoing percutaneous coronary intervention.
Phase:
N/A
Details
Lead Sponsor:
University Hospital, Gentofte, Copenhagen
Treatments:
Abciximab Antibodies, Monoclonal Immunoglobulin Fab Fragments